MRD Could See More Use as Biomarker or Endpoint in the Future, FDA Says
Medical Health News,
Kenneth C. Anderson, MD The FDA recently released a draft guidance to assist with the use of minimal residual disease (MRD) as…
MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool
Overview of attention for article published in Seminars in Hematology (ScienceDirect), March 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Among the highest-scoring outputs from this source (#32 of 1,017)
-
High Attention Score compared to outputs of the same age (90th percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Mentioned by
- news
- 1 news outlet
- 14 X users
- patent
- 6 patents
- 1 Facebook page
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 26 Mendeley